
Parametros:
Nome molecular: [17a-methyl-17b-hydroxy-1,4-androstadien-3-one]
Peso molecular: 300.44
Fórmula: C20H28O2
Ponto de fusão: N/A
Produtor: Ciba (Originalmente)
Data de criação oficial: 1956
Dose efetiva: 25-50mgs (doses abaixo de 5mg e acima de 100mg são relatadas)
Meia-Vida: 6-8 horas na forma oral. E entre 48-72h na forma injetável.
Tempo de detecção no corpo: Maior do que 6 semanas
Índice Anabólico/Androgênico (Variação): 90-210:40-60
Hepatotóxica: Sim
Aromatiza: Sim
Converte-se em DHT: Não
Acne: Sim
Retenção hídrica: Sim
Pressão Alta: Sim

LINKS AQUI:
http://www.consultdrminas.com/aesthetic/hrt.html
http://forums.steroid.com/anabolic-steroids-questions-answers/269806-hepatoxicty-fact-fiction.html#.UPxW-CeABMg%C2%A0
http://ajpendo.physiology.org/content/ajpendo/284/1/E120.full.pdf
http://ajpendo.physiology.org/content/284/1/E120.long
https://books.google.com.br/books?id=4BQGCAAAQBAJ&pg=PA132&lpg=PA132&dq=neutral+steroids&source=bl&ots=qFwefppd1S&sig=ALKPR9dSqgbPG8AfPvpRizvRU_8&hl=pt-BR&sa=X&ved=0ahUKEwi42OzLosPTAhVLIpAKHYX8AK8Q6AEIdDAN#v=onepage&q=neutral%20steroids&f=false
https://fisiculturismo.com.br/forum/topic/100373-o-mito-da-alta-hepatoxidade-dos-ester%C3%B3ides-dudu//
http://dicasdemusculacao.org/dianabol-um-potente-volumizador/
http://sistemarenalfisiologia.blogspot.com.br/2009/11/reabsorcao-tubular.html
http://www.consultdrminas.com/aesthetic/hrt.html
https://www.eroids.com/forum/steroids-qa/steroid-cycles/maximizing-cycles

referencias dos parametros:
Vischer E, Meystre C, Wettstein A. Helv Chim Acta 38 (1955):1502
Kruskemper, H L, Anabolic Steroids, Academic Press, New York, 1968
Relative importance of 5alpha reduction for the androgenic and HL-inhibiting activities of delta-4-3-ketosteroids, Steroids 29 (1997):331-48.
Effect of anabolic steroid (metandionon) on plasma LH-FSH, and testosterone and on the response to intravenous administration of LRH. Holma P. Adlecreutz. Acta Endocrinol (Copenh) 1976 Deca;83(4):856-64
Clin Sci (Lond). 1981 Apr;60(4):457-61
Brain Res. 1998 May 11;792(2):271-6.
Br Med J. 1975 May 31;2(5969):471-3.
Lancet 1979 Nov 24;2(8152):1120-3, Hepatic angiosarcoma associated with androgenic-anabolic steroids. Falk H, Thomas LB, Popper H, Ishak KG.
J Gastroenterol 2000;35(7):557-62, Multiple hepatic adenomas caused by long-term administration of androgenic steroids for aplastic anemia in association with familial adenomatous polyposis. Nakao A, Sakagami K, Nakata Y, Komazawa K, Amimoto T, Nakashima K, Isozaki H, Takakura N, Tanaka N.
J Pharmacol Toxicol Methods 1995 Aug;33(4):187-95, Toxic effects of anabolic-androgenic steroids in primary rat hepatic cell cultures. Welder AA, Robertson JW, Melchert RB.
Arch Toxicol 1999 Nov;73(8-9):465-72, Evaluation of acute and chronic hepatotoxic effects exerted by anabolic-androgenic steroid stanozolol in adult male rats. Boada LD, Zumbado M, Torres S, Lopez A, Diaz-Chico BN, Cabrera JJ, Luzardo OP.
Med Sci Sports Exerc. 1999 Feb;31(2):243-50, Rat liver lysosomal and mitochondrial activities are modified by anabolic-androgenic steroids. Molano F, Saborido A, Delgado J, Moran M, Megias A.
Clin J Sport Med 1999 Jan;9(1):34-9, Anabolic steroid-induced hepatotoxicity: is it overstated? Dickerman RD, Pertusi RM, Zachariah NY, Dufour DR, McConathy WJ.
Int J Sports Med 1996 Aug;17(6):429-33, Body composition, cardiovascular risk factors and liver function in long-term androgenic-anabolic steroids using bodybuilders three months after drug withdrawal. Hartgens F, Kuipers H, Wijnen JA, Keizer HA.
